Komori
Rohto Pharmaceutical (4527) · InitiativeAdvanced

Realizing new service models, including digital healthcare

First written in FY2020. 2 of 3 entries say "Advanced", first in FY2021. Latest entry: FY2024.

3entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020AdvancedFY2021 – FY20242020: 120202021: 120212022: 020222023: 020232024: 12024
Same theme, other companies
Building a multi-customer service model for digital healthcareA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「We will implement Connect for Customer (D2C platform), which addresses each individual's healthcare through customer data and identifies new needs, and will build relationships of trust with customers and business partners while seeking to expand into B2B and B2B2C.」

    The Company has explicitly set out its direction of expanding digital healthcare from D2C to B2B and B2B2C, while continuing to utilize customer data and advance its DX talent development roadmap.
  2. FY2021AdvancedAnnual report

    「We will implement Connect for Customer (D2C platform), which addresses each individual's healthcare through customer data and identifies new needs, thereby building relationships of trust with customers. We will also formulate and promote a DX talent development roadmap to deepen the knowledge of all employees regarding DX and create an environment conducive to generating ideas for digital applications originating from the front line.」

    The direction of digital healthcare has been developed into specific initiatives: Connect for Customer (D2C platform), customer data utilization and a DX talent development roadmap.
  3. FY2020First statedAnnual report

    「As a new healthcare business model, we will implement next-generation health solutions by addressing digital healthcare, engaging with each individual customer and identifying new needs.」

    The Company has for the first time explicitly identified addressing digital healthcare and a service model that engages directly with individual customers to uncover new needs as means of delivering next-generation health solutions.
Moved together

"Establishing a market position through high-value-added products and new brands" moved the same way as this thread, in the same document, in 2 of its 3 moves.

2222★1234
  1. ★This thread
  2. 1Establishing a market position through high-value-added products and new brands2×
  3. 2Technological Innovation and Strengthening the R&D Platform2×
  4. 3Initiatives to make food and regenerative medicine future pillars of the business2×
  5. 4Advancing six business strategies under Vision 20302×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Rohto Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.